Skip to Main Content
SPRIM
  • Consulting
    • Strategy & Innovation
    • Research & Clinical Services
    • Regulatory & Scientific Affairs
    • Medical Marketing & Engagement
  • Ventures
  • News
    • News & Blog
    • Case Studies
    • Publications
  • About
    • Leadership
    • Locations
  • Contact
back to News & Blog

Obvio-19 – Interview with CheddarTv

04.8.2020
Ventures

ObvioHealth is Invested in the Fight Against COVID-19

ObvioHealth’s Matty Culbreth- Notaro speaks on Cheddar-TV to breakdown Obvio-19, a virtual research study designed to measure COVID-19 prevalence, symptoms and immune response in the United States.

We also recommend

blog

Coronavirus Outbreak: Medical Staff Vulnerable, Telemedicine the Solution?

blog

Real World Data and Evidence Revolutionize Clinical Research

blog

ObvioHealth Launches Virtual COVID-19 Symptoms & Immune Response Registry

blog

Travecta Therapeutics Secures $15 Million in Financing

blog

ObvioHealth Secures $17 Million in Latest Investment Round

blog

ObvioHealth and Hôpital Paris Saint-Joseph Announce Partnership to Track COVID-19 in Oncology Patients

SPRIM Logo
  • Consulting
    • Strategy & Innovation
    • Research & Clinical Services
    • Regulatory & Scientific Affairs
    • Medical Marketing & Engagement
  • News
    • Case Studies
    • News & Blog
    • Publications
    • Digital & AI
  • About
    • SPRIM Ventures
    • Leadership
    • Locations
    • Our Industries

© 2025 SPRIM. All Rights Reserved

  • Privacy Policy
  • Terms & Conditions
  • Sitemap
  • Contact Us
  • Facebook
  • Linkedin

© 2025 SPRIM. All Rights Reserved